In the Press

The most up to date information about Endomimetics, press releases & media features.

Recent Stories

October 10, 2024

Endomimetics™ Awarded $300 Thousand Phase I SBIR Grant to Automate and Evaluate a Novel 3D In Vitro Model for Use in Atherosclerosis Drug Discovery and Development

Read Moreimg
September 17, 2024

Endomimetics™ Awarded $2.8 Million Phase II SBIR Grant to Develop and Evaluate the Potential of Bionanomatrix™ to Improve Performance and Patient Outcomes in the Treatment of Brain Aneurysms

Read Moreimg
November 7, 2023

Endomimetics™ Awarded $292 Thousand, One-Year NIH/SBIR Grant to Develop and Evaluate Potential of Bionanomatrix™ to Reduce Infectious and Inflammatory Complications of Knee Arthroplasty

Read Moreimg
November 7, 2023

Endomimetics™ Awarded $292 Thousand, One-Year NIH/SBIR Grant to Develop and Evaluate Potential of Bionanomatrix™ to Reduce Infectious and Inflammatory Complications of Knee Arthroplasty

Read Moreimg
February 14, 2023

Endomimetics™ Announces a Research Collaboration Agreement with BISCO, Inc., to Support Development of a Dental Application of Bionanomatrix™

Read Moreimg

Press, Media
Partnerships

At Endomimetics, we are committed to improving outcomes for patients undergoing surgical procedures and device implantation. To support us in the mission, we are continually seeking collaborations and strategic partnerships with leading medical device companies worldwide to advance our early- and clinical-stage programs.

If you would like to learn more about partnering with Endomimetics, please contact us at:

Media Contact:

Reid Millican, MS
Director, Business Development

[email protected]

Investor Contact:

Reid Millican, MS
Director, Business Development

[email protected]

Dr. Joseph Garner

Chief Executive Officer

[email protected]